文献速递肥胖与代谢综合征糖尿病

重度肥胖青少年接受减重手术的长期结局(FABS-5+):一项前瞻性随访分析

Long-term outcomes of bariatric surgery in adolescents with severe obesity (FABS-5+): a prospective follow-up analysis.
PubMed 文献 · Lancet Diabetes Endocrinol · 2017-01-06

该研究对青少年期接受Roux-en-Y胃旁路术的58例患者进行5-12年前瞻性随访,平均随访8.0年,平均BMI由58.5 kg/m²降至41.7 kg/m²,平均变化-29.2%,高血压、血脂异常和2型糖尿病患病率均显著下降,但随访时部分患者存在轻度贫血、甲状旁腺功能亢进和维生素B12偏低。

要点

  • 青少年期Roux-en-Y胃旁路术后平均8.0年,平均BMI由58.5 kg/m²降至41.7 kg/m²,平均变化-29.2%。
  • 高血压患病率由47%降至16%,血脂异常由86%降至38%,2型糖尿病由16%降至2%,均显著下降。
  • 随访时46%患者有轻度贫血,45%有甲状旁腺功能亢进,16%有维生素B12偏低。

核心结论

  • Roux-en-Y胃旁路术为年轻成人带来显著且持久的体重下降和心血管代谢获益。
  • 术后长期健康维护应关注膳食补充剂的依从性以及微量营养素缺乏的筛查和管理。

研究设计与样本

  • 前瞻性随访分析,纳入在美国一家儿科学术医学中心因临床重度肥胖接受Roux-en-Y胃旁路术的13-21岁青少年队列。
  • FABS研究于2001年5月至2007年2月期间74人接受手术,其中58人符合FABS-5+研究条件、可定位并同意随访评估。
  • 随访时间为术后5-12年,评估BMI、合并症、微量营养素状态、安全性及其他风险。
  • FABS研究注册号ClinicalTrials.gov NCT00776776。

主要发现

  • 基线平均年龄17.1岁(SD 1.7),平均BMI 58.5 kg/m²(SD 10.5)。
  • 平均随访8.0年(SD 1.6;范围5.4-12.5)时,平均年龄25.1岁(SD 2.4),平均BMI 41.7 kg/m²(SD 12.0),平均BMI变化-29.2%(SD 13.7)。
  • 血压升高患病率从27/57(47%)降至9/55(16%),p=0.001。
  • 血脂异常患病率从48/56(86%)降至21/55(38%),p<0.0001;2型糖尿病患病率从9/56(16%)降至1/55(2%),p=0.03。
  • 随访时58例中25例(46%)有轻度贫血(即不需要干预),22例(45%)有甲状旁腺功能亢进,8例(16%)维生素B12低于正常切点。

临床怎么用

  • Roux-en-Y胃旁路术后长期健康维护应关注膳食补充剂的依从性以及微量营养素缺乏的筛查和管理。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Little is known about the long-term outcomes of bariatric surgery for severe adolescent obesity, raising questions about the durability of early responses to surgery. We aimed to analyse long-term (>5 years) outcomes of Roux-en-Y gastric bypass in a cohort of young adults who had undergone the operation during adolescence, in the Follow-up of Adolescent Bariatric Surgery at 5 Plus Years (FABS-5+) extension study. METHODS: A cohort of young people aged 13-21 years underwent Roux-en-Y gastric bypass for clinically severe obesity at a paediatric academic medical centre in the USA. We did a prospective follow-up analysis of these patients' outcomes 5-12 years after surgery. Outcomes assessed included BMI, comorbidities, micronutrient status, safety, and other risks. The FABS study is registered with ClinicalTrials.gov, number NCT00776776. FINDINGS: Between May, 2001, and February, 2007, 74 young people underwent Roux-en-Y gastric bypass in the FABS study. Of these, 58 individuals were eligible for the FABS-5+ study, could be located, and agreed to follow-up assessment. At baseline, the mean age of the cohort was 17·1 years (SD 1·7) and mean BMI was 58·5 kg/m2 (10·5). At mean follow-up of 8·0 years (SD 1·6; range 5·4-12·5), the mean age of the cohort was 25·1 years (2·4) and mean BMI was 41·7 kg/m2 (12·0; mean change in BMI -29·2% [13·7]). From baseline to long-term follow-up, significant declines were recorded in the prevalence of elevated blood pressure (27/57 [47%] vs 9/55 [16%]; p=0·001), dyslipidaemia (48/56 [86%] vs 21/55 [38%]; p<0·0001), and type 2 diabetes (9/56 [16%] vs 1/55 [2%]; p=0·03). At follow-up, 25 (46%) of 58 patients had mild anaemia (ie, not requiring intervention), 22 (45%) had hyperparathyroidism, and eight (16%) had low amounts of vitamin B12 (ie, below the normal cutpoint). INTERPRETATION: Roux-en-Y gastric bypass surgery resulted in substantial and durable bodyweight reduction and cardiometabolic benefits for young adults. Long-term health maintenance after Roux-en-Y gastric bypass should focus on adherence to dietary supplements and screening and management of micronutrient deficiencies. FUNDING: Ethicon Endosurgery, National Center for Advancing Translational Sciences (US National Institutes of Health).

来源:Lancet Diabetes Endocrinol,查看原文。版权归原作者所有。

引用

  1. Inge TH, Jenkins TM, Xanthakos SA, et al. Long-term outcomes of bariatric surgery in adolescents with severe obesity (FABS-5+): a prospective follow-up analysis. Lancet Diabetes Endocrinol. 2017. PMID: 28065736. doi:10.1016/S2213-8587(16)30315-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。